Search the hub
Showing results for tags 'Cancer'.
Found 547 results
-
News Article
Cancer checks: Record number of patients referred in England
Patient Safety Learning posted a news article in News
A record 2.7 million people were referred for cancer checks in the last year, NHS England has said. It comes after figures suggested the Covid pandemic saw numbers dramatically decline in 2020. But at least 30,000 people are still waiting to start treatment. Charities have welcomed the increase in referrals but warned of the "devastating" impact the pandemic has had on cancer care. Referrals for suspected cancer remain at about 16% higher than pre-pandemic levels and rose overall from 2.4 million to 2,65m in the past 12 months. Dame Cally Palmer, national cancer director for NHS England, said there were still 30,000 people who had not started treatment due to the pandemic but that the new figures suggested some progress. She said: "We are going further and faster than ever before in our ambitions to diagnose more cancers at an earlier stage so that we can save more lives." It is "vital that we keep these referral rates high", she added. Read full story Source: BBC News, 2 May 2022 -
Content ArticleThis webpage by the British Association of Dermatologists contains a selection of resources about skin cancer and sun safety for patients. it describes the different types of skin cancer, how to get moles checked and how to stay safe in the sun.
-
Content ArticleThis report represents the views of organisations and experts who responded to the Department of Health & Social Care's call for evidence on its Women's Health Strategy. The call for evidence was released in March 2021. This report focuses on submissions received from 436 organisations and individuals with expertise in women’s health, including the charity sector (34%), academia (22%), industry (10%), clinicians (7%), professional bodies (7%), pressure groups (7%), NHS organisations (3%), parliamentary groups (2%), royal colleges (1%), local government (1%), think tanks (1%) and others (6%).
-
News Article
Study reveals clues to cancer causes and potential for personalised treatment
Patient Safety Learning posted a news article in News
Analysis of thousands of tumours has unveiled a treasure trove of clues about the causes of cancer, representing a significant step towards the personalisation of treatment, a study suggests. Researchers say that for the first time it is possible to detect patterns – called mutational signatures – in the DNA of cancers. These provide clues including about whether a patient has had past exposure to environmental causes of cancer such as smoking or UV light, for example. This is important as these signatures allow doctors to look at each patient’s tumour and match it to specific treatments and medications. Dr Andrea Degasperi, research associate at the University of Cambridge and first author, said: “Whole genome sequencing gives us a total picture of all the mutations that have contributed to each person’s cancer. “With thousands of mutations per cancer, we have unprecedented power to look for commonalities and differences across NHS patients, and in doing so we uncovered 58 new mutational signatures and broadened our knowledge of cancer.” The findings are now being incorporated into the NHS as researchers and clinicians now have the use of a digital tool called FitMS that will help them identify the mutational signature and potentially inform cancer management more effectively. Read full story Source: The Independent, 21 April 2022 You may also be interested to read hub blog: Genetic profiling and precision medicine – the future of cancer treatment -
Content ArticleIn patient experience research, participants frequently report the impact that mesothelioma has on their mental health yet there have been very few studies specifically focused on mental health and mesothelioma. In patient experience research, participants frequently report the impact that mesothelioma has on their mental health yet there have been very few studies specifically focused on mental health and mesothelioma. This new study from the Mesothelioma UK research centre aims to create an understanding of the impact of mesothelioma on the mental health of patients, their families and close friends, and what people do to improve their mental health and well-being.
-
News Article
NHS urges people to attend vital lung cancer check-ups in England
Patient Safety Learning posted a news article in News
NHS leaders are urging people to attend vital lung cancer check-ups as figures reveal almost two-thirds of those invited are not coming forward. The NHS targeted lung health check service offered in some parts of England aims to help diagnose cancer at an earlier stage when treatment may be more successful. Current and former smokers aged between 55 and 74 are invited to speak to a healthcare professional and, if they have a higher chance of developing lung cancer, are offered a scan of their lungs. Doctors are keen to reach those who may not have sought help for symptoms during the pandemic and could be living with undiagnosed lung cancer. People diagnosed at the earliest stage are nearly 20 times more likely to survive for five years than those whose cancer is caught late, according to the NHS. The NHS has already diagnosed 600 people with the disease in travelling trucks, which visit convenient community sites across the UK, such as supermarkets and sports centres, aiming to make it easier for people to access check-ups. But figures show only a third (35%) of patients go to their lung health check when invited by the NHS. “These lung checks can save lives,” said Dame Cally Palmer, the NHS cancer director. “By going out into communities we find more people who may not have otherwise realised they have lung cancer, with hundreds already diagnosed and hundreds of thousands due to be invited." Read full story Source: The Guardian, 19 April 2022 -
Content ArticleAn increasing number of cancer patients are using the internet to better understand their disease and connect with others facing the same challenges. Online cancer communities have developed into resources that highlight new research and evolving treatments. Combined with increasing health literacy and social media, they have enabled some patients to become experts in their cancer. This article in the journal JCO Oncology Practice examines the role of expert patients (e-patients) in advancing cancer medicine, and looks at opportunities available to those who wish to become more involved in research advocacy. The authors found that e-patients play a greater role in their own care and in larger conversations regarding practice, research, and policy. They highlight that clinicians can engage e-patients as partners in cancer care to work together towards improving healthcare access and outcomes for people with cancer.
-
News Article
NI Health: Quarter of cancer patients diagnosed in A&E
Patient Safety Learning posted a news article in News
More than a quarter of cancers in Northern Ireland are being diagnosed in hospital emergency departments, according to Cancer Research UK. The study, published in The Lancet Oncology, was supported by NI Cancer Registry at Queen's University Belfast. It looked at 857,068 cases diagnosed between 2012 and 2017 in six countries including Australia, Denmark and the UK. Clare Crossey, 35, from Lurgan was diagnosed with acute myeloid leukaemia in February 2018 after being admitted to hospital as an emergency. The 35-year-old mother-of-two, who is a domiciliary care assistant, suddenly became very unwell with symptoms including tiredness and bruising. She told BBC News NI she had contacted her local health centre, where a GP told her she was being overly anxious. Ms Crossey said she had panicked, fearing she may have leukaemia after looking up her symptoms on the internet. "I had a feeling that things weren't right," she said. "The doctor did not agree with my suspicions as they passed me the number of the Samaritans helpline, a prescription for beta blockers and told me to wait a week for blood tests." She said: "I went to Craigavon's A&E, they did blood tests and within hours a consultant broke the news to me that I might have leukaemia." The medical team told her that had she waited any longer to come to the emergency department, she could have died, said Ms Crossley. Barbara Roulston, from Cancer Research UK, said the study confirmed too many people were only being diagnosed with cancer once their health had deteriorated to a point when they needed to go to their emergency department. "We need to reduce the number of cancer diagnoses that are happening in this way," she said. "That means renewed focus on early diagnosis and prevention through things like better awareness of symptoms, better uptake of screening programs and the way to do that is to get funding for the cancer strategy which was published recently. "If we don't, the risk is that we will start to see cancer survival going backwards." Read full story Source: BBC News, 7 April 222 -
Content ArticleThis report by the Health and Social Care Commons Select Committee examines why cancer outcomes in England remain behind other comparable countries. For example, 58.9% of people in England diagnosed with colon cancer will live for five years or more, compared to 66.8% in Canada and 70.8% in Australia. The report identifies key issues in early diagnosis, access to treatment, variation in services and research and innovation, and makes recommendations aimed at improving cancer survival rates in England.
-
Content ArticleThis article in the British Journal of General Practice aimed to develop a safety-netting intervention to reduce delays in cancer diagnosis in primary care. To develop the tool, patient representatives, GPs and nurse practitioners were invited to a series of co-design workshops. These workshops suggested the intervention format and content should incorporate visual and written communication specifying clear timelines for monitoring symptoms and when to present back. Participants also agreed that they needed to be available in paper and electronic forms, be linked to existing computer systems and be able to be delivered within a 10-minute consultation. The output of this process was the Shared Safety Net Action Plan (SSNAP), a safety-netting intervention to assist the timely diagnosis of cancer in primary care.
-
News Article
NHS not making progress on early cancer diagnosis
Patient Safety Learning posted a news article in News
The NHS in England is struggling to make progress on its flagship target to diagnose three-quarters of cancer cases at an early stage, MPs are warning. The Health and Social Care Committee said staffing shortages and disruption from the pandemic were causing delays. Some 54% of cases are diagnosed at stages one and two, considered vital for increasing the chances of survival. By 2028, the aim is to diagnose 75% of cases in the early stages, but there has been no improvement in six years. It means England - as well as other UK nations - lag behind comparable countries such as Australia and Canada when it comes to cancer survival. If the lack of progress continues, the committee warned that it could lead to more than 340,000 people missing out on an early cancer diagnosis. The Department of Health said it recognised "business as usual is not enough" and said it was developing a new 10-year cancer plan. But a spokesman said progress was already being made, with a network of 160 new diagnostic centres being opened.R Read full story Source: BBC News, 5 April 2022 -
News Article
New algorithm will improve bowel-cancer patient care
Patient Safety Learning posted a news article in News
An algorithm which can predict how long a patient might spend in hospital if they’re diagnosed with bowel cancer could save the NHS millions of pounds and help patients feel better prepared. Experts from the University of Portsmouth and the Portsmouth Hospitals University NHS Trust have used artificial intelligence and data analytics to predict the length of hospital stay for bowel cancer patients, whether they will be readmitted after surgery, and their likelihood of death over a one or three-month period. The intelligent model will allow healthcare providers to design the best patient care and prioritise resources. Bowel cancer is one of the most common types of cancer diagnosed in the UK, with more than 42,000 people diagnosed every year. Professor of Intelligent Systems, Adrian Hopgood, from the University of Portsmouth, is one of the lead authors on the new paper. He said: “It is estimated that by 2035 there will be around 2.4 million new cases of bowel cancer annually worldwide. This is a staggering figure and one that can’t be ignored. We need to act now to improve patient outcomes. “This technology can give patients insight into what they’re likely to experience. They can not only be given a good indication of what their longer-term prognosis is, but also what to expect in the shorter term. “If a patient isn’t expecting to find themselves in hospital for two weeks and suddenly they are, that can be quite distressing. However, if they have a predicted length of stay, they have useful information to help them prepare. “Or indeed if a patient is given a prognosis that isn’t good or they have other illnesses, they might decide they don’t want a surgical option resulting in a long stay in hospital.” Read full story Source: University of Plymouth, 30 March 2022 -
Content Article
The challenges of volunteering in the NHS
50 Diary posted an article in Workforce and resources
.png.f376e4249fc2956c30d362380dbfef7a.png)
In this blog, Imagen Gowan* writes about her experience of volunteering at a Macmillan Information & Support Centre at her local hospital. She explains what compelled her to start volunteering and what her role involves, as well as exploring some challenges that volunteers in the NHS face. She identifies the need for more training, and greater efforts to preserve morale and a sense of belonging amongst both staff and volunteers. -
News Article
NHS trust apologises over death of woman, 27, after cancer misdiagnosis
Patient Safety Learning posted a news article in News
An NHS trust has apologised over the death of a 27-year-old events manager after a locum gynaecologist mistook aggressive cervical cancer for a hormonal or bowel problem. The family of Porsche McGregor-Sims, who died a day after being admitted to Queen Alexandra hospital in Portsmouth, told her inquest that she had felt she was not listened to and that the misdiagnosis had robbed them of a chance to say goodbye. The area coroner Rosamund Rhodes-Kemp said the case was one of the most “shocking and traumatic” she had dealt with and she would write to Portsmouth hospitals university NHS trust expressing her concern. In December 2019, McGregor-Sims’ GP referred her to a consultant after she complained of abdominal pain and vaginal bleeding. She saw Dr Peter Schlesinger, an agency locum at the Queen Alexandra hospital, at the end of January 2020. He did not physically examine her and believed her symptoms were linked to changing hormones or irritable bowel syndrome (IBS). After the UK went into lockdown two months later, McGregor-Sims continued to report symptoms but was prescribed antibiotics over the phone and was seen in person only after a GP thought she might have Covid because she had shortness of breath. McGregor-Sims was finally diagnosed with an aggressive form of cervical cancer and on 13 April was taken to hospital, where she died a day later. During the inquest, her family accused Schlesinger of having denied them their chance to say goodbye. Her mother, Fiona Hawke, told him: “You robbed us of the opportunity to prepare for her death and say goodbye to her.” Schlesinger insisted McGregor-Sims’ symptoms – including bleeding after sex – did not lead him to think she had a serious illness. Dr Claire Burton, a consultant gynaecologist, said Schlesinger should have physically examined McGregor-Sims, and apologised for the care she received at the trust. Read full story Source: The Guardian, 24 March 2022 -
Content Article500,000 immunocompromised people, who are at particularly high risk from Covid, live in the UK. Because their weakened immune systems meant they were less likely to have been protected by the first two doses of the Covid-19 vaccine than the general population, the Joint Committee on Vaccination and Immunisation recommended they have a ‘third primary dose’ eight weeks after their second dose (whereas other groups were to get a booster six months after their second dose). But the complexity of this system meant that huge numbers of immunocompromised people were left waiting for a vaccine invitation that never came. In this blog for The King's Fund, Gemma Peters, Chief Executive of Blood Cancer UK, examines the challenges people with blood cancer and others with compromised immunity faced during the Covid-19 vaccine roll-out. She argues that NHS England must fix these issues by establishing a register of immunocompromised people and a reliable way of contacting them, tackling misinformation and publicly acknowledging the issues people with compromised immune systems have faced to date.
-
News Article
Surgery and cancer care in England will have long delays for years
Patient Safety Learning posted a news article in News
Patients waiting for surgery and cancer care in England will face long delays for years to come, MPs have warned in a new report that is highly critical of both ministers and NHS bosses. The already-record 6.1 million-strong waiting list for vital treatment will keep growing and officials are “too optimistic” that plans to tackle it will succeed, the public accounts committee (PAC) said in a report on Wednesday. “For the next few years it is likely that waiting time performance for cancer and elective care will remain poor and the waiting list for elective care will continue to grow,” it said. The committee of MPs, which monitors spending across Whitehall, acknowledges Covid-19’s role in contributing to the ballooning backlog and lengthening waiting times. But it singled out years of inaction by the Department of Health and Social Care (DHSC) for particular blame. Patients waiting for surgery and cancer care in England will face long delays for years to come, MPs have warned in a new report that is highly critical of both ministers and NHS bosses. The already-record 6.1 million-strong waiting list for vital treatment will keep growing and officials are “too optimistic” that plans to tackle it will succeed, the public accounts committee (PAC) said in a report on Wednesday. “For the next few years it is likely that waiting time performance for cancer and elective care will remain poor and the waiting list for elective care will continue to grow,” it said. The committee of MPs, which monitors spending across Whitehall, acknowledges Covid-19’s role in contributing to the ballooning backlog and lengthening waiting times. But it singled out years of inaction by the Department of Health and Social Care (DHSC) for particular blame. Read full story Source: The Guardian, 16 March 2022 -
Content ArticleThis is the report and formal minutes of a House of Commons Public Accounts Committee session that examined the issues surrounding NHS backlogs and waiting times in England. The session particularly focused on accountability in how NHS England and the Department for Health and Social Care manage workforce and resources. At the end of December 2021, 6.07 million patients were waiting for elective care, the biggest waiting list since records began. Only 64% (3.87 million) of these patients had been waiting for less than 18 weeks, compared with the performance standard which requires 92% to have been waiting for less than 18 weeks. Similarly, in December 2021, only 67% of patients with an urgent referral for suspected cancer were treated within 62 days compared with a requirement for 85% to be treated within that time. The report highlights that although the Covid-19 pandemic had a significant effect on the backlog, NHS waiting time performance had declined steadily in the years before the pandemic.
-
News ArticleLess than half of women are being seen following an urgent breast cancer referral, as NHS performance drops to a new low. ‘Alarming’ new NHS figures have shown just 47% of women in England referred “urgently” for breast cancer symptoms were seen by a specialist within two weeks. For women without symptoms but referred urgently to see a specialist, just 49% were seen within two weeks. In both cases this is the first time since records began that less than 50% cent of women were seen. Within some trusts less than 10% of women referred with symptoms were seen within two weeks, with less than two per cent of women referred to United Lincolnshire Hospitals Trust being seen within this time frame in January. Wes Streeting, Labour shadow health secretary said: “I know from experience the importance of an early cancer diagnosis and quick treatment. It is appalling that most suspected breast cancer patients are left waiting so long before being seen, with the insecurity of not knowing." Baroness Delyth Morgan, chief executive at Breast Cancer Now, said: “It’s alarming that in January, for the first time, less than half of women 47.5 per cent in England who were urgently referred with potential breast cancer symptoms, were seen by a specialist within two weeks." “...the government must consider what immediate steps it can take to reverse this rapid decline. Agonising delays must be replaced with prompt diagnoses for all women – and the sooner breast cancer is diagnosed the greater the chance of treatment being successful.” Read full story Source: The Independent, 11 March 2022
-
News Article
National robotic assisted surgery programme to be established in Wales
Patient Safety Learning posted a news article in News
A national robotic-assisted surgery programme allowing surgeons to perform complex procedures with more precision and control is being introduced in Wales, the Health Minister has announced. The All-Wales Robotic Assisted Surgery Network, developed by health boards, the Life Sciences Hub Wales and the Moondance Cancer Initiative, will provide less invasive surgery for thousands of cancer patients across the country. The surgery involves the use of highly advanced robotic surgical instruments under the control of a surgeon. It will initially be used in Wales for some Colorectal, Upper Gastrointestinal, Urological and Gynaecological cancers. The Welsh Government will support the network with funding of £4.2m over five years, alongside £13.35m provided by health boards over 10 years. Health and Social Services Minister Eluned Morgan said: "The All-Wales Robotic Assisted Surgery Network is an ambitious and important programme helping to improve outcomes for patients and the NHS in Wales. It will put Wales at the forefront of international research for the use of robotic surgical techniques. This pioneering service will also encourage specialist staff to come to Wales to train and practice". It will initially be provided in the Betsi Cadwaladr University Health Board area, with the first patient expected to receive treatment in June. Once fully established, patients in north Wales will no longer need to travel to England to receive robotic-assisted surgery. Read full story Source: Welsh Government, 14 March 2022 -
Content ArticleThis report highlights the importance of embracing a culture of change in the design and delivery of women’s health to achieve national systems and local services fit to meet the expectations and needs of the 21st century woman. It describes the many failings of health services across the world whose default position is to treat women as second-class citizens and place unnecessary barriers to the delivery of high-quality accessible care. The report sets out recommendations, founded on common sense and rooted in the belief that women should be in control of their own bodies.
-
News Article
NHS England to replace cancer targets
Patient Safety Learning posted a news article in News
The two-week wait cancer target should be scrapped and replaced with a different measure, as part of an overhaul of cancer standards, NHS England has said. After piloting a new measure which aims to see 75% of patients given the all-clear or a diagnosis within 28 days of referral, NHS England has recommended .The new “faster diagnosis target” would replace the current ‘two-week wait’ target, which is for 93% to have seen a specialist within two weeks, but not necessarily had a diagnosis. This proposal, and other changes to the way cancer waiting time targets are organised, will be consulted on until 6 April. The nine current cancer targets were created in 2000. The current headline measure along with the two-week wait — a two-month wait from urgent GP referral to first treatment — has not been hit since December 2015. The document containing the proposals said the current two-week standard saw some patients given an appointment at which no test was taken, purely to hit the target. For some suspected cancers, “many trusts… offer outpatient appointments to ensure they hit the target”, without improving diagnosis. The move to scrap the two-week wait was welcomed – with significant caveats — by Cancer Research UK Cancer Research UK chief executive Michelle Mitchell said: “The new Faster Diagnosis Standard is a more meaningful target than the current two-week wait that will hopefully improve early diagnosis. If all trusts met the 75 per cent target, it would be an improvement to where we are now. However, in the long-term to improve cancer survival, we’d like to see a 95 per cent target originally proposed in the 2015 cancer strategy in Sajid Javid’s upcoming 10-year plan for cancer. “We recognise the target was set lower because of a shortage of cancer specialists, critical to diagnosing cancer across the NHS. The government must provide the extra investment they have promised to grow the NHS workforce. Every moment of delay risks more people waiting for diagnosis and treatment.” Read full story (paywalled) Source: HSJ, 10 March 2022 -
Content ArticleThis thesis explores different aspects of risk and safety in healthcare, adding to previous research by studying patient safety in first-contact care, primary care and the emergency department. The author investigated preventable harm and serious safety incidents in primary health care and emergency departments, and found that diagnostic error was the most common type or error. The thesis makes recommendations for safety improvements at all levels of a healthcare system.
-
News ArticleA Scottish hospital has become the first in the UK and one of the first in the world to pilot using artificial intelligence (AI) in its cervical cancer screening programme. University Hospital Monklands has increased capacity by around 25% and improved analysis turn-around times with the measure, which experts said could “revolutionise” the screening process. The system, from medical technology company Hologic, creates digital images of cervical smear slides from samples that have tested positive for Human Papilloma Virus (HPV). These are then reviewed using an advanced algorithm, which quickly assesses the cells in the sample and highlights the most relevant to medical experts, saving them time in identifying and analysing abnormalities. “Preliminary results from the pilot are promising, as the team at University Hospital Monklands has increased capacity by around 25 per cent in the slide assessment and improved analysis turn-around times, as well as allowing screeners to dedicate more time to training on the latest technologies and dealing with difficult-to-diagnose cases,” says Allan Wilson, consultant biomedical scientist at NHS Lanarkshire who is leading the pilot. "Through AI and digital diagnostics, we have the potential to improve outcomes for women not only in Scotland, but around the world.” Samantha Dixon, chief executive of Jo’s Cervical Cancer Trust, welcomed the pilot. “Catching cervical cell changes means they can be treated to prevent them from developing into cervical cancer,” she said. Read full story Source: The Scotsman, 4 March 2022
-
Content ArticleCancer Research UK’s latest analysis of NHS Digital cancer registration data uses the most complete recording to date of cancer rates by ethnicity in England, providing crucial data on how some cancer rates vary by ethnicity. The study found that although a small number of cancer sites have higher incidence rates in Asian, Black and Mixed/Multiple ethnic groups, for the majority of cancer sites these groups have a lower incidence than the White population. Differing prevalence of risk factors and access to/use of health services is likely to explain more of this variation than are genetic factors; if risk factor prevalence changes cancer rates may rise in minority ethnic groups, therefore action to address key risk factors and to improve the cancer experiences and outcomes of people in minority ethnic groups is vital. Improving the collection of ethnicity information in healthcare datasets will support a better understanding of differences in disease, as well as inequalities in cancer and where improvements in the health service can be made.
-
News Article
Study reveals stark disparities in cancer rates between ethnic groups
Patient Safety Learning posted a news article in News
Stark disparities in cancer rates between different ethnic groups have been laid bare in new research showing black people are twice as likely to get prostate cancer while white people have double the chance of getting skin and lung cancers. The analysis of NHS Digital cancer registration data by Cancer Research UK provides the most complete recording ever of cancer rates by ethnicity in England, offering crucial data on how some rates vary. The results are published in the British Journal of Cancer. White people in England are more than twice as likely to get some types of cancer, including melanoma skin cancer, oesophageal, bladder and lung cancers compared with people from black, Asian or mixed ethnic backgrounds, according to the research. Black people are almost three times more likely to get myeloma and almost twice as likely to get prostate cancer compared with white people. The study also found that black people are more likely to get stomach and liver cancers, and Asian people are more likely to get liver cancers. Genetics are thought to play a part in some of the findings, Cancer Research UK said. For example, white people are more likely to get skin cancer because they tend to burn more easily in the sun. Preventable risk factors also appear to be involved, the charity added, as white people are more likely than most minority ethnic groups to smoke or be overweight or obese. These are the two largest risk factors in developing cancer and help explain why white people are more likely to get some types of cancer than other ethnic groups. Read full story Source: The Guardian, 2 March 2022
.png.f376e4249fc2956c30d362380dbfef7a.png)